SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 132 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$24,000
-89.2%
77,278
-75.0%
0.00%
-100.0%
Q1 2022$222,000
-68.3%
309,5690.0%0.00%
-77.8%
Q4 2021$700,000
+566.7%
309,569
+747.7%
0.02%
+800.0%
Q3 2021$105,000
-61.8%
36,520
-49.7%
0.00%
-60.0%
Q2 2021$275,000
-63.2%
72,600
-67.1%
0.01%
-61.5%
Q1 2021$747,000220,6250.01%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 4,652,561$13,027,0005.13%
Orchard Capital Management, LLC 857,138$2,400,0001.02%
Nantahala Capital Management 7,040,487$19,713,0000.61%
OCCUDO QUANTITATIVE STRATEGIES LP 209,040$585,0000.18%
Woodline Partners LP 2,382,522$6,671,0000.18%
RICE HALL JAMES & ASSOCIATES, LLC 1,546,169$4,329,0000.15%
Virtus ETF Advisers LLC 92,771$260,0000.11%
Jump Financial, LLC 155,583$435,0000.07%
GSA CAPITAL PARTNERS LLP 128,626$360,0000.06%
Anson Funds Management LP 95,342$267,0000.05%
View complete list of AKEBIA THERAPEUTICS INC shareholders